Wednesday - November 11, 2026

Ace Therapeutics Highlights In Vivo Pharmacodynamic Evaluation Services to Advance Cardiovascular Drug Development

Ace Therapeutics is highlighting its comprehensive services for in vivo cardiovascular drug evaluation, designed to help clients obtain critical pharmacodynamic data for candidate therapies. New York, United States – November 11, 2026 – Ace Therapeutics, a contract research organization specializing in … Continue reading →